The Future of Road Freight Runs Through Mexico: DSV
Q: How would you define DSV Road Americas’ strategic role within the company’s global road freight network?A: Road…
Novo’s Catalent plant ditched in FDA refiling of SMA drug
Scholar Rock has shed Novo Nordisk’s troubled Catalent facility as a contract manufacturer in its FDA refiling for…
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have…
Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies?
For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to…
Mars–Kellanova EU merger ruling: What the Commission’s decision means for food and snack manufacturers
The ruling in brief:The European Commission concluded the Mars–Kellanova merger was unlikely to materially strengthen the company’s bargaining…
Drees & Sommer to project manage new satellite factory in Berlin
Image courtesy of Ffang/Dreamstime German consultant Drees & Sommer will project manage the building of a factory making…
Business outlook improves despite weak consumer confidence
Finland’s business sector showed further signs of recovery in July, with confidence improving across manufacturing, construction, services and…
The LEGO Group opens its first dedicated manufacturing innovation centre
The LEGO Group has opened its Kornmarken Campus. The facility is the company’s first dedicated global manufacturing innovation…
Novo Nordisk eyes faster drug approvals with Celonis
Novo Nordisk is using Celonis software and AI agents to shorten its clinical development process. The drugmaker could…
Novo Nordisk eyes faster drug approvals with Celonis
Novo Nordisk is using Celonis software and AI agents to shorten its clinical development process. The drugmaker could…
Novo Nordisk eyes faster drug approvals with Celonis
Novo Nordisk is using Celonis software and AI agents to shorten its clinical development process. The drugmaker could…
The 3 letters Brussels won’t be able to shut up about – POLITICO
To ensure the price doesn’t swing wildly, the Commission has a few tools at its disposal. The most…